The government is thinking of letting the states cherry pick the central schemes for rural welfare, a step back from centralized decision-making that it hopes could help quell the accusations that Centre was weakening the federal structure. The idea behind the 'flexifund route' is to allow states the freedom to decide rural development schemes they want to implement and how much of allocation should each get. It would mark a departure...
More »SEARCH RESULT
Chief information commissioner appointment may hit a roadblock-Joseph John
BHOPAL: The state government move to appoint chief information commissioner (CIC) by the end of April may hit a roadblock with the Supreme Court stating Friday that it would lay down guidelines to ensure that posts of information commissioners at the centre and state commissions do not become "property of a political set-up". The post of state's CIC is lying vacant following the retirement of P P Tiwari on March 26...
More »Green tribunal sets aside clearance granted to Jindal-Aarti Dhar
“Entire public hearing was farce and makes mockery of public hearing process” In a significant decision the National Green Tribunal (NGT) on Friday set aside the Environmental Clearance (EC) granted to the 4 MTPA Coal Mining Project of Jindal Steel and Power Ltd (JSPL) and 4 MTPA Coal Washery at Gare in Raigarh district of Chhattisgarh on grounds of faulty public hearing. The company had been granted environmental clearance in May 2009....
More »Manmohan Singh assures civil servants, no 'witch hunt' for taking bold decisions
-IANS Asking civil servants to take bold decisions, Prime Minister Manmohan Singh on Saturday said the government would not indulge in "witch hunting" against them in the name of fighting corruption. " ... it should be our endeavour that there is no witch hunting in the name of fighting corruption," the prime minister said while inaugurating the 7th Civil Services Day event here. "It is our government's commitment to put in place a...
More »Western warnings-R Ramachandran
India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...
More »